{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:18:29Z","timestamp":1792459109130,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016308","name":"Wuxi Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.amjms.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T09:29:45Z","timestamp":1694338185000},"page":"404-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney"],"prefix":"10.1016","volume":"366","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0001","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/156800911795655985","article-title":"VEGF\/VEGFR pathway inhibitors as anti-angiogenic agents: present and future","volume":"11","author":"Sharma","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"issue":"17","key":"10.1016\/j.amjms.2023.09.005_bib0002","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0003","doi-asserted-by":"crossref","first-page":"F1656","DOI":"10.1152\/ajprenal.00275.2009","article-title":"The balance of autocrine VEGF-A and VEGF-C determines podocyte survival","volume":"297","author":"M\u00fcller-Deile","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0004","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ajpath.2013.04.019","article-title":"Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro","volume":"183","author":"Foster","year":"2013","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0005","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3390\/ijms23073825","article-title":"BECLIN1 Is Essential for Podocyte Secretory Pathways Mediating VEGF Secretion and Podocyte-Endothelial Crosstalk","volume":"23","author":"Bork","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db18-0045","article-title":"VEGFC reduces glomerular albumin permeability and protects against alterations in VEGF receptor expression in diabetic nephropathy","volume":"68","author":"Onions","year":"2019","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.amjms.2023.09.005_bib0007","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0008","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.344","article-title":"Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy","volume":"85","author":"Izzedine","year":"2014","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.amjms.2023.09.005_bib0009","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","article-title":"Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature","volume":"45","author":"Usui","year":"2014","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2326-6066.CIR-19-0360","article-title":"Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia","volume":"8","author":"de Almeida","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.amjms.2023.09.005_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00262-020-02676-8","article-title":"Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer","volume":"70","author":"Min","year":"2021","journal-title":"J Cancer Immunol Immunother"},{"issue":"8","key":"10.1016\/j.amjms.2023.09.005_bib0012","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00262-007-0441-x","article-title":"The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients","volume":"57","author":"Osada","year":"2008","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12885-019-5909-5","article-title":"Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness","volume":"19","author":"Bencsikova","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0014","first-page":"1","article-title":"Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease","volume":"11","author":"Tanaka","year":"2021","journal-title":"J Sci Rep"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cei.13090","article-title":"Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1","volume":"192","author":"Hoeres","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjms.2023.09.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115112","article-title":"Epigallocatechin gallate relieves asthmatic symptoms in mice by suppressing HIF-1\u03b1\/VEGFA-mediated M2 skewing of macrophages","volume":"202","author":"Yang","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.amjms.2023.09.005_bib0017","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","article-title":"Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo","volume":"92","author":"Gabrilovich","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0018","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/0008-5472.CAN-14-3023","article-title":"VEGF-A\/VEGFR Inhibition Restores Hematopoietic Homeostasis in the Bone Marrow and Attenuates Tumor GrowthAntiangiogenesis Restores Bone Marrow Vascular Niche","volume":"76","author":"O'Donnell","year":"2016","journal-title":"Cancer Res"},{"issue":"6573","key":"10.1016\/j.amjms.2023.09.005_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/380439a0","article-title":"Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene","volume":"380","author":"Ferrara","year":"1996","journal-title":"Nature"},{"issue":"6573","key":"10.1016\/j.amjms.2023.09.005_bib0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0021","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/cs1010439","article-title":"Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo","volume":"101","author":"Harper","year":"2001","journal-title":"Clin Sci (Colch)"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210565","article-title":"Interplay of vascular endothelial growth factor receptors in organ-specific vessel maintenance","volume":"219","author":"Karaman","year":"2022","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jcb.20142","article-title":"Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor","volume":"93","author":"Huckle","year":"2004","journal-title":"J Cell Biochem"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0024","doi-asserted-by":"crossref","first-page":"e40589","DOI":"10.1371\/journal.pone.0040589","article-title":"Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus","volume":"7","author":"Veron","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1681\/ASN.2007050629","article-title":"HIV-1 upregulates VEGF in podocytes","volume":"19","author":"Korgaonkar","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.amjms.2023.09.005_bib0026","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.2013070752","article-title":"Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice","volume":"25","author":"Veron","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0027","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.ki.5002101","article-title":"Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss","volume":"71","author":"Baelde","year":"2007","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0028","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.kint.2017.03.029","article-title":"Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis","volume":"92","author":"Kinashi","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03385-x","article-title":"Lymphangiogenesis in renal fibrosis arises from macrophages via VEGF-C\/VEGFR3-dependent autophagy and polarization","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0030","first-page":"1","article-title":"Attenuated lymphatic proliferation ameliorates diabetic nephropathy and high-fat diet-induced renal lipotoxicity","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1436-1","article-title":"Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db\/db mice","volume":"10","author":"Hwang","year":"2019","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0032","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/his.13716","article-title":"Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy","volume":"73","author":"Pfister","year":"2018","journal-title":"Histopathology"},{"issue":"24","key":"10.1016\/j.amjms.2023.09.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-021-02656-9","article-title":"Regorafenib-induced renal-limited thrombotic microangiopathy: a case report and review of literatures","volume":"23","author":"Yin","year":"2022","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0035","article-title":"Cutaneous thrombogenic vasculopathy associated with bevacizumab therapy","volume":"20","author":"Kiuru","year":"2014","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0036","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","volume":"24","author":"Boll\u00e9e","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-018-1194-9","article-title":"Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report","volume":"20","author":"Yamada","year":"2019","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0038","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cellsig.2012.11.017","article-title":"Inhibition of nephrin activation by c-mip through Csk\u2013Cbp\u2013Fyn axis plays a critical role in Angiotensin II-induced podocyte damage","volume":"25","author":"Yu","year":"2013","journal-title":"Cell Signalling"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0039","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1002\/ctm2.460","article-title":"CMIP interacts with WT1 and targets it on the proteasome degradation pathway","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin Transl Med"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2012.426","article-title":"Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy","volume":"83","author":"Sendeyo","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0041","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfn625","article-title":"Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: a class effect?","volume":"24","author":"Winn","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjms.2023.09.005_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.579603","article-title":"Thrombotic microangiopathy and acute kidney injury induced after intravitreal injection of vascular endothelial growth factor inhibitors VEGF blockade-related TMA after intravitreal use","volume":"7","author":"Hanna","year":"2020","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0043","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1523-1755.2005.67101.x","article-title":"Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells","volume":"67","author":"Villegas","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0044","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00441-018-2850-x","article-title":"Reabsorption in the proximal tubuli\u2014ultrastructural evidence for a novel aspect of renal VEGF trafficking","volume":"374","author":"Vitlov Uljevi\u0107","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88000-5","article-title":"Vegfa promoter gene hypermethylation at HIF1\u03b1 binding site is an early contributor to CKD progression after renal ischemia","volume":"11","author":"S\u00e1nchez-Navarro","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0046","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.2014010060","article-title":"Quaggin SE. Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney","volume":"26","author":"Dimke","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0047","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2353\/ajpath.2009.080792","article-title":"Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease","volume":"175","author":"Hakroush","year":"2009","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.amjms.2023.09.005_bib0048","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/labinvest.2017.77","article-title":"Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction","volume":"97","author":"Hasegawa","year":"2017","journal-title":"Lab Invest"},{"issue":"22","key":"10.1016\/j.amjms.2023.09.005_bib0049","doi-asserted-by":"crossref","first-page":"e15094","DOI":"10.14814\/phy2.15094","article-title":"Expanded renal lymphatics improve recovery following kidney injury","volume":"9","author":"Baranwal","year":"2021","journal-title":"Physiol Rep"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0050","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1002\/jcp.27648","article-title":"VEGF-C attenuates renal damage in salt-sensitive hypertension","volume":"234","author":"Beaini","year":"2019","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0051","doi-asserted-by":"crossref","first-page":"eaaw5075","DOI":"10.1126\/sciadv.aaw5075","article-title":"Lymphangiogenesis in kidney and lymph node mediates renal inflammation and fibrosis","volume":"5","author":"Pei","year":"2019","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0052","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.kint.2017.03.029","article-title":"Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis","volume":"92","author":"Kinashi","year":"2017","journal-title":"J Kidney Int"},{"issue":"11","key":"10.1016\/j.amjms.2023.09.005_bib0053","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1134\/S0006297907110041","article-title":"Gene expression for VEGF-A, VEGF-C, and their receptors in murine lymphocytes and macrophages","volume":"72","author":"Stepanova","year":"2007","journal-title":"Biochemistry (Moscow)"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0054","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","article-title":"Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization","volume":"172","author":"Mor","year":"2004","journal-title":"J Immunol"},{"issue":"1-2","key":"10.1016\/j.amjms.2023.09.005_bib0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cellimm.2009.01.006","article-title":"Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells","volume":"256","author":"Shin","year":"2009","journal-title":"Cell Immunol"},{"issue":"6892","key":"10.1016\/j.amjms.2023.09.005_bib0056","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nature00821","article-title":"VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism","volume":"417","author":"Gerber","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0057","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijc.26094","article-title":"VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2","volume":"130","author":"Ziogas","year":"2012","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0058","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0059","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41385-020-0308-4","article-title":"Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation","volume":"14","author":"Maisel","year":"2021","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0060","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.ajpath.2012.07.021","article-title":"Critical role of VEGF-C\/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis","volume":"181","author":"Krebs","year":"2012","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.amjms.2023.09.005_bib0061","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.ekir.2019.09.003","article-title":"Association of T cell\u2013derived inflammatory cytokines with acute kidney injury and mortality after cardiac surgery","volume":"4","author":"Moledina","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1016\/j.amjms.2023.09.005_bib0062","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.4049\/jimmunol.178.9.5899","article-title":"NKT cell activation mediates neutrophil IFN-\u03b3 production and renal ischemia-reperfusion injury","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0063","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12079-018-0486-y","article-title":"Comprehensive network map of interferon gamma signaling","volume":"12","author":"Bhat","year":"2018","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0064","article-title":"Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis","volume":"5","author":"do Valle Duraes","year":"2020","journal-title":"Insight"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1681\/ASN.2015070820","article-title":"T-bet enhances regulatory T cell fitness and directs control of Th1 responses in crescentic GN","volume":"28","author":"Nosko","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0066","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.kint.2019.05.012","article-title":"Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis","volume":"96","author":"Gan","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0067","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00880-2021","article-title":"VEGF-C\/VEGFR-3 signalling in macrophages ameliorates acute lung injury","volume":"59","author":"Yamashita","year":"2022","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0068","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2004.10.011","article-title":"GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice","volume":"21","author":"Eubank","year":"2004","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0069","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.placenta.2004.09.001","article-title":"Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women","volume":"26","author":"Rajakumar","year":"2005","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0070","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jcmm.14027","article-title":"Autocrine VEGF signalling on M2 macrophages regulates PD-L1 expression for immunomodulation of T cells","volume":"23","author":"Lai","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0071","doi-asserted-by":"crossref","first-page":"F406","DOI":"10.1152\/ajprenal.00099.2004","article-title":"TNF-\u03b1 mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling","volume":"288","author":"Misseri","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0072","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1566524017666171106114537","article-title":"VEGFR1 signaling regulates IL-4-mediated arginase 1 expression in macrophages","volume":"17","author":"Zou","year":"2017","journal-title":"Curr Mol Med"},{"issue":"11","key":"10.1016\/j.amjms.2023.09.005_bib0073","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1159\/000511260","article-title":"Recovery of renal function following kidney-specific VEGF therapy in experimental renovascular disease","volume":"51","author":"Engel","year":"2020","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0074","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair","volume":"22","author":"Lee","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ki.2013.405","article-title":"Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor","volume":"85","author":"Alagesan","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0076","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SHK.0000000000001006","article-title":"Role of M2 macrophages in sepsis-induced acute kidney injury","volume":"50","author":"Li","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.amjms.2023.09.005_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107823","article-title":"Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes","volume":"97","author":"Arabpour","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0078","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MAJ.0000000000000569","article-title":"Significance of CD163-positive macrophages in proliferative glomerulonephritis","volume":"350","author":"Li","year":"2015","journal-title":"Am J Med Sci"},{"issue":"16","key":"10.1016\/j.amjms.2023.09.005_bib0079","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"J Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.amjms.2023.09.005_bib0080","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41417-022-00447-4","article-title":"Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophages","volume":"29","author":"Ma","year":"2022","journal-title":"J Cancer Gene Ther"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0081","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.kint.2016.11.026","article-title":"M1 macrophage triggered by Mincle leads to a deterioration of acute kidney injury","volume":"91","author":"Inoue","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1568-1","article-title":"Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons","volume":"20","author":"Kishimoto","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0083","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.160.3.1224","article-title":"Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-\u03baB activation in hemopoietic progenitor cells","volume":"160","author":"Oyama","year":"1998","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.amjms.2023.09.005_bib0084","doi-asserted-by":"crossref","first-page":"39256","DOI":"10.18632\/oncotarget.9684","article-title":"Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors","volume":"7","author":"Salvi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.amjms.2023.09.005_bib0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2016.03.008","article-title":"Pro-lymphangiogenic properties of IFN-\u03b3-activated human dendritic cells","volume":"173","author":"Gagliostro","year":"2016","journal-title":"Immunol Lett"},{"issue":"8","key":"10.1016\/j.amjms.2023.09.005_bib0086","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/TP.0000000000003601","article-title":"Presence of Donor Lymph Nodes Within Vascularized Composite Allotransplantation Ameliorates VEGF-C-mediated Lymphangiogenesis and Delays the Onset of Acute Rejection","volume":"105","author":"Olariu","year":"2021","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0087","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.23186","article-title":"Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18","volume":"58","author":"Tucci","year":"2008","journal-title":"Arthrit Rheumat"},{"issue":"7","key":"10.1016\/j.amjms.2023.09.005_bib0088","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1093\/ndt\/gfp019","article-title":"Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis","volume":"24","author":"Wilde","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0089","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ki.2011.289","article-title":"Increased influx of myeloid dendritic cells during acute rejection is associated with interstitial fibrosis and tubular atrophy and predicts poor outcome","volume":"81","author":"Zuidwijk","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0090","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1523-1755.2005.00502.x","article-title":"Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney","volume":"68","author":"Dong","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0091","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00262-006-0234-7","article-title":"Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2","volume":"56","author":"Mimura","year":"2007","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"10.1016\/j.amjms.2023.09.005_bib0092","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.4049\/jimmunol.0903063","article-title":"B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes","volume":"184","author":"Shrestha","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2023.09.005_bib0093","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0145-2126(03)00188-7","article-title":"Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR)","volume":"28","author":"El-Obeid","year":"2004","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.amjms.2023.09.005_bib0094","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.exphem.2008.04.023","article-title":"VEGF signaling on hematopoietic precursors restricts B-lymphoid commitment in vitro and in vivo","volume":"36","author":"Fragoso","year":"2008","journal-title":"Exp Hematol"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0095","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1096\/fj.201902397R","article-title":"In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells","volume":"34","author":"Shivshankar","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0096","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.amjms.2023.09.005_bib0097","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.ajpath.2020.06.004","article-title":"The renin-angiotensin-aldosterone system (RAAS) is one of the effectors by which vascular endothelial growth factor (VEGF)\/anti-VEGF controls the endothelial cell barrier","volume":"190","author":"Li","year":"2020","journal-title":"J Am J Pathol"},{"key":"10.1016\/j.amjms.2023.09.005_bib0098","article-title":"Renal events in patients receiving Neprilysin inhibitors: a systematic review and meta-analysis","author":"Barbosa","year":"2022","journal-title":"Nephrol Dialy Transplant"},{"key":"10.1016\/j.amjms.2023.09.005_bib0099","article-title":"Dexamethasone inhibits podocyte apoptosis by stabilizing the PI3K\/Akt signal pathway","volume":"2013","author":"Li","year":"2013","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0100","first-page":"1","article-title":"Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease","volume":"11","author":"Tanaka","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5414\/CN110443","article-title":"Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature","volume":"96","author":"Hilburg","year":"2021","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1016\/j.amjms.2023.09.005_bib0102","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/1078155218774895","article-title":"Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab","volume":"25","author":"Vakiti","year":"2019","journal-title":"J Oncol Pharma Pract"},{"issue":"5","key":"10.1016\/j.amjms.2023.09.005_bib0103","doi-asserted-by":"crossref","first-page":"F1016","DOI":"10.1152\/ajprenal.00607.2018","article-title":"Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization","volume":"316","author":"Guise","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.amjms.2023.09.005_bib0104","doi-asserted-by":"crossref","first-page":"F1342","DOI":"10.1152\/ajprenal.00674.2011","article-title":"Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach","volume":"302","author":"Chade","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.amjms.2023.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2015040346","article-title":"Renal therapeutic angiogenesis using a bioengineered polymer-stabilized vascular endothelial growth factor construct","volume":"27","author":"Chade","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.amjms.2023.09.005_bib0106","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.1303116","article-title":"CD47 signaling regulates the immunosuppressive activity of VEGF in T cells","volume":"193","author":"Kaur","year":"2014","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.amjms.2023.09.005_bib0107","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41374-020-0434-3","article-title":"Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis","volume":"100","author":"Julovi","year":"2020","journal-title":"J Lab Invest"},{"key":"10.1016\/j.amjms.2023.09.005_bib0108","doi-asserted-by":"crossref","unstructured":"Nording H, Langer HF. Complement links platelets to innate immunity. Paper presented at: Seminars in immunology 2018: 43\u201352.","DOI":"10.1016\/j.smim.2018.01.003"},{"issue":"3","key":"10.1016\/j.amjms.2023.09.005_bib0109","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10456-016-9515-8","article-title":"Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes","volume":"19","author":"MacDonald","year":"2016","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-39914-8","article-title":"Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury","volume":"9","author":"Oe","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2023.09.005_bib0111","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8811672","article-title":"Human Platelets Take up Anti-VEGF Agents","volume":"2021","author":"Sobolewska","year":"2021","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0112","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10753-012-9537-3","article-title":"Paeoniflorin attenuates lipopolysaccharide-induced permeability of endothelial cells: involvements of F-actin expression and phosphorylations of PI3K\/Akt and PKC","volume":"36","author":"Xu","year":"2013","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.amjms.2023.09.005_bib0113","first-page":"1","article-title":"The protective effects of angelica organic acid against ox-LDL-induced autophagy dysfunction of HUVECs","volume":"20","author":"Li","year":"2020","journal-title":"BMC Complement Med Thera"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923013307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962923013307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:49Z","timestamp":1762082209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962923013307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":113,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0002962923013307"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2023.09.005","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}